- Shares of CEL-SCI Corp. (NYSE:CVM) are down 11.6% in afternoon trading after announcing last night that its underwriter, Kingswood Capital Markets, had agreed to increase the size of a previous offering.
- The closing date of the offering is June 11.
- CEL-SCI's only late-stage product is Multikine (leukocyte interleukin) which is in phase 3 for head and neck cancer and phase 1 for human papillomavirus.
CEL-SCI down 11% on $31.7M capital raise
Recommended For You
About CVM Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CVM | - | - |
CEL-SCI Corporation |